Latest Insider Transactions at Viridian Therapeutics, Inc.\De (VRDN)
This section provides a real-time view of insider transactions for Viridian Therapeutics, Inc.\De (VRDN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Viridian Therapeutics, Inc.\DE to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Viridian Therapeutics, Inc.\DE's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 27
2024
|
Stephen F. Mahoney President and CEO |
BUY
Open market or private purchase
|
Direct |
21,400
+50.0%
|
$492,200
$23.33 P/Share
|
|
Sep 27
2024
|
Thomas W. Beetham Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+45.45%
|
$115,000
$23.41 P/Share
|
|
Sep 13
2024
|
Fairmount Funds Management LLC Director |
BUY
Open market or private purchase
|
Indirect |
1,600,000
+31.71%
|
$28,800,000
$18.75 P/Share
|
|
Mar 28
2024
|
Fairmount Funds Management LLC Director |
BUY
Other acquisition or disposition
|
Indirect |
5,859
+0.32%
|
-
|
|
Mar 28
2024
|
Fairmount Funds Management LLC Director |
SELL
Other acquisition or disposition
|
Indirect |
5,859
-100.0%
|
-
|
|
Jan 22
2024
|
Fairmount Funds Management LLC Director |
BUY
Open market or private purchase
|
Indirect |
476,190
+20.56%
|
$9,999,990
$21.0 P/Share
|
|
Jun 16
2023
|
Lara Meisner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
27
-0.09%
|
$756
$28.35 P/Share
|
|
Jun 16
2023
|
Lara Meisner Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
27
+0.09%
|
$621
$23.03 P/Share
|
|
Jun 15
2023
|
Lara Meisner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,269
-7.04%
|
$63,532
$28.02 P/Share
|
|
Jun 15
2023
|
Lara Meisner Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,269
+6.58%
|
$52,187
$23.03 P/Share
|
|
Jun 06
2023
|
Lara Meisner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,126
-14.61%
|
$128,150
$25.02 P/Share
|
|
Jun 06
2023
|
Lara Meisner Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,126
+12.74%
|
$92,268
$18.51 P/Share
|
|
Jun 05
2023
|
Lara Meisner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
499
-1.64%
|
$12,475
$25.03 P/Share
|
|
Jun 05
2023
|
Lara Meisner Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
499
+1.61%
|
$8,982
$18.51 P/Share
|
|
Jun 02
2023
|
Lara Meisner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,875
-5.89%
|
$45,000
$24.21 P/Share
|
|
Jun 02
2023
|
Lara Meisner Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,875
+5.56%
|
$26,250
$14.0 P/Share
|
|
Apr 12
2023
|
Scott Dunseth Myers Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
4,000
+1.52%
|
$100,000
$25.37 P/Share
|
|
Mar 13
2023
|
Scott Dunseth Myers Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
5,500
+2.11%
|
$159,500
$29.15 P/Share
|
|
Mar 09
2023
|
Lara Meisner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
29,971
-100.0%
|
$869,159
$29.07 P/Share
|
|
Feb 06
2023
|
Scott Dunseth Myers Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
250,000
+50.0%
|
-
|
|
Feb 02
2023
|
Jonathan Violin Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-10.4%
|
$1,800,000
$36.8 P/Share
|
|
Jan 23
2023
|
Lara Meisner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
6,843
-100.0%
|
$239,505
$35.66 P/Share
|
|
Jan 23
2023
|
Lara Meisner Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,843
+35.74%
|
$123,174
$18.52 P/Share
|
|
Jan 17
2023
|
Barrett Katz Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
24,853
-100.0%
|
$919,561
$37.21 P/Share
|
|
Jan 17
2023
|
Barrett Katz Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,853
+50.0%
|
$571,619
$23.03 P/Share
|
|
Jan 13
2023
|
Barrett Katz Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,147
-100.0%
|
$153,439
$37.01 P/Share
|
|
Jan 13
2023
|
Barrett Katz Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,147
+50.0%
|
$95,381
$23.03 P/Share
|
|
Jan 10
2023
|
Barrett Katz Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
47,377
-100.0%
|
$1,658,195
$35.3 P/Share
|
|
Jan 10
2023
|
Barrett Katz Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
47,377
+50.0%
|
$1,089,671
$23.03 P/Share
|
|
Jan 09
2023
|
Barrett Katz Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
12,623
-100.0%
|
$416,559
$33.04 P/Share
|
|
Jan 09
2023
|
Barrett Katz Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,623
+50.0%
|
$290,329
$23.03 P/Share
|
|
Dec 21
2022
|
Lara Meisner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
16,326
-100.0%
|
$473,454
$29.19 P/Share
|
|
Dec 21
2022
|
Lara Meisner Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,326
+50.0%
|
$375,498
$23.03 P/Share
|
|
Dec 20
2022
|
Lara Meisner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
600
-100.0%
|
$16,800
$28.07 P/Share
|
|
Dec 20
2022
|
Lara Meisner Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
600
+50.0%
|
$13,800
$23.03 P/Share
|
|
Dec 16
2022
|
Lara Meisner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,297
-100.0%
|
$36,316
$28.44 P/Share
|
|
Dec 16
2022
|
Lara Meisner Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,297
+50.0%
|
$29,831
$23.03 P/Share
|
|
Dec 15
2022
|
Lara Meisner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
300
-100.0%
|
$8,400
$28.08 P/Share
|
|
Dec 15
2022
|
Lara Meisner Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
300
+50.0%
|
$6,900
$23.03 P/Share
|
|
Dec 14
2022
|
Lara Meisner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
15,656
-100.0%
|
$438,368
$28.12 P/Share
|
|
Dec 14
2022
|
Lara Meisner Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,656
+50.0%
|
$360,088
$23.03 P/Share
|
|
Dec 12
2022
|
Lara Meisner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
600
-100.0%
|
$16,800
$28.05 P/Share
|
|
Dec 12
2022
|
Lara Meisner Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
600
+50.0%
|
$13,800
$23.03 P/Share
|
|
Nov 15
2022
|
Lara Meisner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
8,125
-100.0%
|
$178,750
$22.05 P/Share
|
|
Nov 15
2022
|
Lara Meisner Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,125
+50.0%
|
$113,750
$14.0 P/Share
|
|
Aug 17
2022
|
Fairmount Funds Management LLC Director |
BUY
Open market or private purchase
|
Indirect |
425,531
+23.78%
|
$9,787,213
$23.5 P/Share
|
|
Jun 01
2022
|
Jonathan Violin Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
30,000
-5.87%
|
$360,000
$12.2 P/Share
|
|
May 02
2022
|
Jonathan Violin Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
30,000
-5.55%
|
$390,000
$13.04 P/Share
|
|
Apr 04
2022
|
Jonathan Violin Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,600
-0.66%
|
$64,800
$18.93 P/Share
|
|
Apr 01
2022
|
Jonathan Violin Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
26,400
-4.62%
|
$475,200
$18.92 P/Share
|